NHO Revive Becomes Nebraska's Only Site for Groundbreaking Prostate Cancer Clinical Trial
NHO Revive becomes Nebraska's only site for a Johnson & Johnson Phase 3 trial testing a novel immune therapy for prostate cancer. NEBRASKA'S , NE, UNITED STATES, July 22, 2026 /EINPresswire.com/ -- The study, sponsored by Johnson …